Our second hypothesis is that PET/CT imaging targeting NTR1, GRPR, and PSMA could achieve non-invasive stratification of PCa-bearing models and prostate cancer lesions in vivo in patients, providing experimental and preliminary clinical data for non-invasive stratified diagnosis of PCa patients in the future. This evidence concerns the gene NTSR1 and prostate cancer.